| [1] |
WANG Fei, HANG Yongfu, WANG Wei.
Influence of argumented renal clearance on teicoplannin serum concentrations in critical ill patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1043-1048.
|
| [2] |
HE Jie, LIU Dongxue, ZHONG Lingjun, SHAO Hua, HU Linlin.
Establishment of a limited sampling strategy to estimate micafungin exposure in critically ill patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1264-1271.
|
| [3] |
LI Nan，HUANG Haitao，YONG Xiaolan.
Pharmaceutical care for a patient misdiagnosed as Staphylococcus intermedius pulmonary infection
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(9): 1067-1071.
|
| [4] |
SHEN Hui-feng, ZHANG Sui-yang, CHANG Yan, REN Juan.
Use of SAS iteration and Monte Carlo simulation to optimize use of Meropenem
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(5): 529-535.
|
| [5] |
SUN Yuan, ZHA Wei-bin, ZHOU Fang, WU Xiao-lan, ZHANG Jing-wei, WANG Guang-ji.
Relation between bacterial efflux pump and antibiotic resistance
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(5): 593-600.
|
| [6] |
LI Xiao-ning, LI Juan, YAO Yong-hong.
Analysis on resistance of Acinetobacter Baumannii and the extended spectrum beta-lactamases and carbapenemases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(1): 30-33.
|
| [7] |
LUO Ping, XU Bo, LU Yong-ling, ZHOU Hong.
Expression of antibacterial peptide gloverin in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(6): 701-704.
|
| [8] |
LIU Kang, XU Qiang.
Effects of roxithromycin on contact sensitivity and functions of T Lympho-cytes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(4): 382-386.
|
| [9] |
ZHANG Yong-Qing, WANG Rui, ZHU Man, ZHANG Jian-Peng, ZHANG Yong-Mei, TONG Jun.
Observation of morphology in Escherichia coli with atom microscope during the cefmetazole-induced post-antibiotic effect period
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(10): 1123-1127.
|
| [10] |
DAI De.
Protective effect of baicalin-mediated on mice spinal ganglion cells against gentamicin-induced ototoxicity
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(8): 939-941.
|
| [11] |
ZHU Xin-Bo, WANG Ju-Xing1, DONG Miao-Wu, WANG Shan-Juan, FANG Zhou-Xi, LIN Dan, JING Xiao-Dong.
Experimental study on ototoxicity of gentamycin at therapeutic doses in infant or adult guinea pigs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(3): 329-332.
|
| [12] |
LI Yan-Yu, PEI Fei, ZHAO Xi-Lin, WANG Rui.
Mutant selection window and mutant prevention concentration for antimicrobial agents
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(1): 1-7.
|
| [13] |
WANG Lin-Hui, JI Hui, REN Ping, LI Dong-Xia, WEI Dong-Zhi.
Therapeutic effects of tinidazole membrane on experimental periodontitis and its oral mucosa irritation in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(1): 39-43.
|
| [14] |
LIANG Bei-Bei, LIU Qing-Feng, ZHAO Tie-Mei, ZHU Man, FANG Yi, WANG Rui.
Comparison of in vitro activity of gatifloxacin and other four fluoquinolones against clinical isolates
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(1): 48-51.
|
| [15] |
FANG Yi, WANG Rui, PEI Fei, CHAI Dong, ZHU Man, LIANG Bei-Bei, WANG Xi-Ping.
Tolerability of gatifloxacin mehanesulfanae orally for 10 days in Chinese health volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(1): 70-73.
|
